• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of novel therapy targeting dendritic cells for Crohn's disease

Research Project

Project/Area Number 15590685
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKeio University

Principal Investigator

IWAO Yasushi  Keio University, Department of Medicine, Assistant Professor, 医学部, 講師 (40168547)

Co-Investigator(Kenkyū-buntansha) HIBI Toshifumi  Keio University, Department of Medicine, Professor, 医学部, 教授 (50129623)
WATANABE Mamoru  Tokyo Medical & Dental University, Dept of Medicine, Professor, 医学部, 教授 (10175127)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2004: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2003: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsCrohn's disease / dendritic cell / natural killer T cell / antigen / inflammatory bowel disease / Th1 / Th2
Research Abstract

Crohn's disease(CD) is a chronic inflammatory process involving the gastrointestinal tract, characterised by discontinuous and transmural inflammation. Although the etiology of CD is not fully understood, accumulating evidence suggests that dysregulation of the local immune system is pivotal in the pathogenesis of CD. Studies from humans and experimental murine colitis models indicate that in CD, the local immune response tends to be predominantly T helper cell type 1(Th1) and is reflected by local release of cytokines such as tumor necrosis factor (TNF)-□, interleukin (IL)-12, and IL-18. However, it has not been elucidated what triggers the Th1 immune response in CD. In the present study, we attempted to establish the purification of dendrtic cells from mesenteric lymph nodes(MLN) and to analyze the immune cascade in the mesenteric lymph nodes of human CD.
We established the purification of dendrtic cells from MLN by density gradient centrifugation and immunomagnetic depletion of CD3^+,CD11b^+ and CD16^+ cells followed by positive isolation with CD4^+. The analysis of cells obtained from MLNs revealed that the proportion of DC1 was increased in the MLN of CD compared to ulcerative colitis and control and that CD4+ T lymphocytes from the MLN of CD show a Th1 profile.
This is the first study to report the characterization of MLN dendritic cells and cytokine profiles of the MLN CD4+ T cells from human IBD patients. This study shows that MLN dendritic cells have considerable effects in the pathogenesis of IBD. The MLN may be the place where the dysregulated immune responses, such as Th1 in CD, first occur.

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (24 results)

All 2005 2004 2003 Other

All Journal Article (18 results) Publications (6 results)

  • [Journal Article] Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.2005

    • Author(s)
      Sato I, Hibi T, et al.
    • Journal Title

      GUT (in press)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Thi immune response.2005

    • Author(s)
      Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T
    • Journal Title

      GUT (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.2005

    • Author(s)
      Sato T, Hibi T, et al.
    • Journal Title

      GUT (in press)

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Granulocytapheresis is useful as an alterative therapy in patients with steroid-refractory or -dependent ulcerative colitis.2004

    • Author(s)
      Naganuma M.Iwao Y, et al.
    • Journal Title

      Inflamm Bowel Dis 10

      Pages: 251-257

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] T-bet up-regulation and subsequent interleukin 12 stimulation are essential for the induction of Th1 mediated immunopathology in Crohn's disease.2004

    • Author(s)
      Matsuoka K, Hibi T, et al.
    • Journal Title

      GUT 53

      Pages: 1303-1308

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Human intestinal epithelial cell-derived interleukin (IL)-18, along with IL-2, IL-7 and IL-15, a potent synergistic factor for the proliferation of intraepithelial lymphocytes.2004

    • Author(s)
      Okazawa A, Hibi T, et al.
    • Journal Title

      Clin Exp Immunol 136

      Pages: 269-276

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.2004

    • Author(s)
      Sato T, Hibi T, et al.
    • Journal Title

      Gastroenterology 126

      Pages: 829-839

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Granulocytapheresis is useful as an alterative therapy in patients with steroid-refractory or -dependent ulcerative colitis.2004

    • Author(s)
      Naganuma M, Funakoshi S, Sakuraba A, Takagi H, Inoue N, Ogata H, Iwao Y, Ishii H, Hibi T
    • Journal Title

      Inflamm Bowel Dis 10(3)

      Pages: 251-257

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] T-bet up-regulation and subsequent interleukin 12 stimulation are essential for the induction of Th1 mediated immunopathology in Croha's disease.2004

    • Author(s)
      Matsuoka K, Inoue N, Sato T, Okamoto S, Hisamatsu T, Kishi Y, Sakuraba A, Hitotsumatsu O, Fukushima T, Kanai T, Watanabe M, Ishii H, Hibi T
    • Journal Title

      Gut 53(9)

      Pages: 1303-1308

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Human intestinal epithelial cell-derived interleukin(IL)-18, along with IL-2, IL-7 and IL-15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes.2004

    • Author(s)
      Okazawa A, Kanai T, Nakamaru K, Sato T, Inoue N, Ogata H, Jwao Y, Ikeda M, Kawamura T, Makita S, Uraushihara K, Okamoto R, Yamazaki M, Kurimoto M, Ishii H, Watanabe M, Hibi T
    • Journal Title

      Clin Exp Immunol 136(2)

      Pages: 269-276

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.2004

    • Author(s)
      Sato T, Kanai T, Watanabe M, Sakuraba A, Okamoto S, Nakai T, Okazawa A, Inoue N, Totsuka T, Yamazaki M, Kroczek RA, Fukushima T, Ishii H, Hibi T
    • Journal Title

      Gastroenterology 126(3)

      Pages: 829-839

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Granulocytapheresis is useful as an alterative therapy in patients with steroid-refractory or-dependent ulcerative colitis.2004

    • Author(s)
      Naganuma M, Iwao Y, et al.
    • Journal Title

      Inflamm Bowel Dis 10・3

      Pages: 251-257

    • Related Report
      2004 Annual Research Report
  • [Journal Article] T-bet up-regulation and subsequent interleukin 12 stimulation are essential for the induction of Th1 mediated immunopathology in Crohn's disease.2004

    • Author(s)
      Matsuoka K, Hibi T, et al.
    • Journal Title

      GUT 53・9

      Pages: 1303-1308

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Human intestinal epithelial cell-derived interleukin(IL)-18, along with IL-2, IL-7 and IL-15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes.2004

    • Author(s)
      Okazawa A, Hibi T, et al.
    • Journal Title

      Cin Exp Immunol 136・2

      Pages: 269-276

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Hyperexpression of inducible costimulator its contribution on lamina propria T cells in inflammatory bowel disease.2004

    • Author(s)
      Sato T, Hibi T, et al.
    • Journal Title

      Gastroenterology 126・3

      Pages: 829-839

    • Related Report
      2004 Annual Research Report
  • [Journal Article] CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.2004

    • Author(s)
      Makita S, Watanabe M, et al.
    • Journal Title

      J Immunol 173・5

      Pages: 3119-3130

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice.2003

    • Author(s)
      Takagi H, Hibi T, et al.
    • Journal Title

      Scand J Gastroenterol 38

      Pages: 837-844

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Contrasting action of IL-12 and IL-15 in the development of dextran sodium sulfate colitis in mice.2003

    • Author(s)
      Takagi T, Kanai T, Okazawa A, Sato T, Takaishi H, Inoue N, Ogata H, Hoshino K, Takeda K, Akira S, Watanabe M, Jshii H, Hibi T
    • Journal Title

      Scand J Gastroenterol 38(8)

      Pages: 837-844

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Publications] Sato T, et al.: "Hyperexpression of Inducible Costimulator and Its Contribution on Lamina Propria T cells in Inflammatory Bowel Disease."Gastroenterology. 126(3). 829-839 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takagi H, et al.: "Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice."Scand J Gastroenterol. 38(8). 837-844 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamazaki M, et al.: "Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis."J Immunol. 171(3). 1556-1563 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Ezaki T, et al.: "A specific genetic alteration on chromosome 6 in ulcerative colitis-associated colorectal cancers."Cancer Res. 63(13). 3747-3749 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Kanai T, et al.: "Macrophage-derived IL-18 targeting for the treatment of Crohn's disease."Curr Drug Targets Inflamm Allergy. 2(2). 131-136 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hibi T, et al.: "Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis."J Gastroenterol. 38(8). 740-746 (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi